bernard carroll psychiatrist known laying smack drug industry spin fantastic post health care renewal read deals marketing science surrounding use risperdal treatment resistant depression topic i discussed length site previously teaser campaign aims shape favorable climate opinion drug experimercials commercially strategic clinical trials journal publications really infomercials stakeholders major corporations key opinion leaders kols leading medical journals several million patients suffer nonresponsive depression winners kols corporations big losers patients plot thickens begin see picture appearance editorial self dealing including product placement corporate client editor incompetent possibly dishonest journal review process appearance somebody went way two places insert false claim efficacy report negative clinical trial depth reporting excellent i vouch dr carroll analysis situation note closely matches investigation risperdal depression studies industry academia buckets money collide outcome predictable